Online Submissions

Already have a Username/Password for Chinese Journal of Clinicians?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines

Author Guidelines

Chinese Journal of Clinicians(ISSN 1674-0785) is an open accessed,peer reviewed scholarly journal, publishes original research articles, technical advances and study protocols in any area of medical science or clinical practice online and on DVD-ROM. The fields covered include anesthesiology, cardiology, complementary medicine, critical care, dermatology, emergency medicine, endocrinology, ethics, gastroenterology, genetics, geriatrics, gynecology, health services research, hematology, imaging, immunology, infectious diseases, informatics, medical education, musculoskeletal disorders, nephrology, neurology, nuclear medicine, nursing, obstetrics, oncology, ophthalmology, oral health, otolaryngology, palliative care, pathology, pediatrics, pharmacology, physiology, primary care, psychiatry, public health, respirology, research methodology, surgery and urology.

Criteria for publication

To be appropriate for Chinese Journal of Clinicians, articles need to be of special importance and broad interest. This will be determined by peer review and by the advice of a member of the editorial board or somebody of equivalent standing. There are no restrictions on the length of an article, but authors should bear in mind that excessive length deters potential readers

Submission process

Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The submitting author takes responsibility for the article during submission and peer review. To facilitate rapid publication and to minimize administrative costs, Chinese Journal of Clinicians accepts only online submission.

During submission you will be asked to provide a cover letter. Please use this to explain why your manuscript should be published in the journal.

Assistance with the process of manuscript preparation and submission is available from the editorial office .

Publication and peer review processes

Submitted manuscripts will be sent to peer reviewers, unless they are either out of scope or below threshold for the journal, or the presentation or written English is of an unacceptably low standard. They will generally be reviewed by two experts with the aim of reaching a first decision as soon as possible. In addition, advice on whether the article is of sufficient significance for publication in Chinese Journal of Clinicians will generally be obtained from a member of the Editorial Board or a researcher of equivalent standing. Reviewers are asked to declare any competing interests.

We ask all authors to provide the contact details (including email addresses) of at least four potential peer reviewers for their manuscript. These should be experts in their field of study, who will be able to provide an objective assessment of the manuscript. Any suggested peer reviewers should not have published with any of the authors of the manuscript within the past five years and should not be members of the same research institution, nor should they be on the Editorial Board of the journal unless they work precisely in that field. Suggested reviewers will be considered alongside potential reviewers identified by their publication record or recommended by Editorial Board members.

Reviewers are asked whether the manuscript is scientifically sound and whether it is of sufficient significance for publication in Chinese Journal of Clinicians. They are told that should the work be sound but of limited significance, the authors will be given the option of publication without further review. In cases where there is strong disagreement either among peer reviewers or between the authors and peer reviewers, advice is sought from a member of the journal's Editorial Board. The journal allows a maximum of two revisions of any manuscript. All appeals should be directed to the Medical Editor. The ultimate responsibility for editorial decisions lies with the Editor-in-Chief.

Once an article is accepted, it is published in Chinese Journal of Clinicians immediately as printing version. The paper will subsequently be published in both fully browseable web form, and as a formatted PDF; the article will then be available through Chemical Abstract,CNKI and Wanfang Data. Authors will be able to check the progress of their paper through the submission system at any time by logging into http:// /, their personalized section of the site.

Editorial Policys

Any manuscript, or substantial parts of it, submitted to the journal must not be under consideration by any other journal although it may have been deposited on a preprint server. The manuscript should not have already been published in any journal or other citable form, with the exception that the journal is willing to consider peer-reviewing manuscripts that are translations of articles originally published in another language. In this case, the consent of the journal in which the article was originally published must be obtained and the fact that the article has already been published must be made clear on submission and stated in the abstract. Authors who publish in Chinese Journal of Clinicians retain copyright to their work.

Submission of a manuscript to Chinese Journal of Clinicians implies that all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Research carried out on humans must be in compliance with the Helsinki Declaration, and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Methods section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. Informed consent must also be documented. Manuscripts may be rejected if the editorial office considers that the research has not been carried out within an ethical framework, e.g. if the severity of the experimental procedure is not justified by the value of the knowledge gained. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.

We ask authors of Chinese Journal of Clinicians papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, to follow the Acknowledgements.

For all articles that include information or clinical photographs relating to individual patients, written and signed consent from each patient to publish must also be stated.

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.

The involvement of medical writers or anyone else who assisted with the preparation of the manuscript content should be acknowledged, along with their source of funding. If medical writers are not listed among the authors, it is important that their role be acknowledged explicitly.

Submission of a manuscript to Chinese Journal of Clinicians implies that readily reproducible materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.

Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

Nucleotide sequences

Nucleotide sequences can be deposited with the GenBank (National Center for Biotechnology Information), DNA Data Bank of Japan (DDBJ), European Molecular Biology Laboratory (EMBL/EBI) , or Nucleotide Sequence Database.

Protein sequences

Protein sequences can be deposited with SwissProt or the Protein Information Resource (PIR)


Protein structures can be deposited with one of the members of the Worldwide Protein Data Bank. Nucleic Acids structures can be deposited with the Nucleic Acid Database at Rutgers. Crystal structures of organic compounds can be deposited with the Cambridge Crystallographic Data Centre.

Chemical structures and assays

Structures of chemical substances can be deposited with PubChem Substance. Bioactivity screens of chemical substances can be deposited with PubChem BioAssay.

Microarray data

Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society and must deposit microarray data in one of the public repositories, such as ArrayExpress, Gene Expression Omnibus (GEO) or the Center for Information Biology Gene Expression Database (CIBEX).

Computional modeling

We encourage authors to prepare models of biochemical reaction networks using the Systems Biology Markup Language and to deposit the model with the BioModels database, as well as submitting it as an additional file with the manuscript.


We encourage authors to deposit copies of their plasmids as DNA or bacterial stocks with Addgene, a non-profit repository, or PlasmID, the Plasmid Information Database at Harvard.

Preparing main manuscript text

File formats

The following word processor file formats are acceptable for the main manuscript document:

  • Microsoft Word (version 2 and above)
  • Rich text format (RTF)
  • Portable document format (PDF)

Users of other word processing packages should save or convert their files to RTF before uploading.

Manuscript sections for Research articles

Manuscripts for Research articles submitted to Chinese Journal of Clinicians should be divided into the following sections:

  • Title page
  • Abstract
  • Background or Introduction
  • Methods
  • Results
  • Discussion
  • Conclusions
  • List of abbreviations used (if any)
  • Competing interests
  • Acknowledgements
  • References
  • Figure legends (if any)
  • Tables and captions (if any)

The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].

Title page

This should list the title of the article. The title should include the study design. The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding author should also be indicated.


The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background or Objective, the context and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract.


The background/Introduction section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a very brief statement of what is being reported in the article.


This should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate.

Results and Discussion

The Results and Discussion may be combined into a single section or presented separately. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results and discussion sections may also be broken into subsections with short, informative headings.


This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

List of abbreviations

If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests.

Competing interests

A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.


Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.

The role of a medical writer must be included in the acknowledgements section, including their source(s) of funding. Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.


All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.

Examples of the Chinese Journal of Clinicians reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading.

Chinese Journal of Clinicians reference style

Article within a journal

    • 1. Tanaka S, Yokoyama C, Kawamura I, et al. Conservative Medication Follow-up for Over 20 Years of a Patient With Ischemic Heart Disease After Diagnosis of Chronic Total Occlusion of the 3 Main Coronary Arteries. Circ J,2008,72(7):1205-1209.
    • Article within a journal supplement
    • 2. Hien PT. Sexual coercion within marriage in Quang Tri, Vietnam. Cult Health Sex, 2008 ,(10 Suppl):S177-187.
    • Article within conference proceedings
    • 3. Ruhin-Poncet B. 32nd Congress of the French Association of Maxillofacial Surgeons. Nantes, 15-17 March 2007.
    • Book chapter, or article within a book
    • 4. Wagner H,Bladt S.Plant Drug Analysis.Berlin:Springer,1996:384.
    • 5. Mayers LS,Grossen NE.Analysis of independent group designs.In:W.H.Freeman.Behavioural research,theory,procedure and design.San Francisco:W.H.Freeman and Company,1958:237-252.

Preparing illustrations and figures

Figures should be provided as separate files. Each figure should comprise only a single file. There is no charge for the use of color.


The following file formats can be accepted:

  • EPS (preferred format for diagrams)
  • PDF (also especially suitable for diagrams)
  • PNG (preferred format for photos or images)
  • Microsoft Word (version 5 and above; figures must be a single page)
  • PowerPoint (figures must be a single page)
  • TIFF
  • JPEG

Figure legends

The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words.

Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.

Preparing tables

Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.

Smaller tables considered to be integral to the manuscript can be pasted into the end of the document text file. Such tables should be formatted using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text. Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines. Commas should not be used to indicate numerical values. Color and shading should not be used.

Style and language


Currently, Chinese Journal of Clinicians can accept manuscripts written in English. Spelling should be US English or British English, but not a mixture.

Gene names should be in italic, but protein products should be in plain type.

There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is no restriction on the number of figures or tables. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.

Chinese Journal of Clinicians will edit manuscripts shortly before they are accepted and published. The editing is only to correct such things as misused words, spelling errors, missing references or incomplete citation information. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. Non-native speakers of English may choose to make use of a copyediting service.


Abbreviations should be used as sparingly as possible. They can be defined when first used or a list of abbreviations can be provided preceding the acknowledgements and references.


SI Units should be used throughout (liter and molar are permitted, however).


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.

Copyright Notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.


Author Fees

This journal charges the following author fees.

Fast-Track Review: 350.00 (USD)
With the payment of this fee, the review, editorial decision, and author notification on this manuscript is guaranteed to take place within 4 weeks.

Article Publication: 550.00 (USD)
If this paper is accepted for publication, you will be asked to pay an Article Publication Fee to cover publications costs.

If you do not have funds to pay such fees, you will have an opportunity to waive each fee. We do not want fees to prevent the publication of worthy work.

Chinese Journal of Clinicians